Minera Neurosciences Aktie News & Nachrichten
[WKN: A1171S | Symbol: NERV]Realtimekurs
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-117, and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.
Es konnten keine Nachrichten über Minera Neurosciences gefunden werden.